HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvana Pilotti Selected Research

Dermatofibrosarcoma

1/2017Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment.
7/2016Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases.
2/2016Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP).
1/2016Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss.
10/2011Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Silvana Pilotti Research Topics

Disease

82Neoplasms (Cancer)
01/2020 - 02/2003
17Sarcoma (Soft Tissue Sarcoma)
11/2019 - 09/2002
11Squamous Cell Carcinoma of Head and Neck
01/2018 - 10/2006
10Myxoid Liposarcoma
03/2020 - 07/2007
10Carcinoma (Carcinomatosis)
01/2018 - 01/2003
8Chordoma
10/2018 - 11/2004
8Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
03/2012 - 07/2004
7Colorectal Neoplasms (Colorectal Cancer)
03/2014 - 06/2004
7Breast Neoplasms (Breast Cancer)
10/2010 - 02/2003
6Liposarcoma
01/2019 - 07/2007
6Ewing Sarcoma (Sarcoma, Ewing)
11/2018 - 07/2003
5Mesothelioma
01/2020 - 10/2010
5Dermatofibrosarcoma
01/2017 - 10/2011
5Melanoma (Melanoma, Malignant)
02/2015 - 08/2004
5Ovarian Neoplasms (Ovarian Cancer)
02/2015 - 12/2002
5Adenocarcinoma
06/2014 - 06/2003
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2014 - 04/2003
4Disease Progression
01/2019 - 01/2014
4Papillary Thyroid Cancer
02/2013 - 10/2005
4Ovarian Epithelial Carcinoma
01/2013 - 08/2004
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2010 - 07/2004
3Genomic Instability
11/2018 - 10/2010
3Solitary Fibrous Tumors
10/2018 - 05/2010
3Inflammation (Inflammations)
11/2017 - 10/2005
3Follicular Adenocarcinoma
02/2013 - 10/2005
2Thyroid Neoplasms (Thyroid Cancer)
01/2020 - 02/2013
2Monosomy
01/2020 - 12/2009
2Anaplastic Thyroid Carcinoma
01/2020 - 02/2013
2Papillary Carcinoma
01/2020 - 05/2008
2Aggressive Fibromatosis (Desmoid)
11/2017 - 09/2007
2Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2017 - 01/2016
2Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2017 - 12/2009
2Salivary Gland Neoplasms (Salivary Gland Cancer)
05/2016 - 06/2014
2Clear Cell Sarcoma
02/2015 - 02/2012
2Extraskeletal Myxoid Chondrosarcoma
12/2013 - 10/2012
2Alveolar Soft Part Sarcoma
09/2013 - 02/2009
2Neurofibrosarcoma (MPNST)
12/2009 - 09/2003
2Genetic Translocation (Chromosomal Translocation)
08/2009 - 07/2007
2Carcinogenesis
05/2008 - 10/2004
2Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
09/2007 - 10/2006

Drug/Important Bio-Agent (IBA)

22Imatinib Mesylate (Gleevec)FDA Link
10/2018 - 07/2003
19Proteins (Proteins, Gene)FDA Link
01/2020 - 04/2003
12TrabectedinIBA
03/2020 - 07/2007
11Pharmaceutical PreparationsIBA
01/2019 - 12/2006
11Biological ProductsIBA
11/2016 - 06/2004
10Phosphotransferases (Kinase)IBA
01/2018 - 02/2004
9Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
11/2015 - 11/2004
8Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
03/2012 - 02/2004
7Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018 - 02/2004
6Biomarkers (Surrogate Marker)IBA
01/2018 - 06/2004
6Messenger RNA (mRNA)IBA
01/2018 - 02/2004
5RNA (Ribonucleic Acid)IBA
11/2019 - 09/2003
5Sunitinib (Sutent)FDA Link
06/2018 - 02/2009
5Tyrosine Kinase InhibitorsIBA
01/2018 - 07/2004
5Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
07/2016 - 09/2007
5DNA (Deoxyribonucleic Acid)IBA
03/2014 - 06/2006
5LigandsIBA
08/2010 - 02/2004
4Formaldehyde (Formol)FDA Link
01/2020 - 04/2003
4EnzymesIBA
01/2020 - 04/2005
4MicroRNAs (MicroRNA)IBA
01/2017 - 04/2012
4tyrosine receptor (receptor, tyrosine)IBA
07/2016 - 07/2010
4Cyclin-Dependent Kinase Inhibitor p16IBA
07/2007 - 06/2003
3ParaffinIBA
01/2020 - 04/2003
3Tyrosine (L-Tyrosine)FDA Link
01/2018 - 05/2008
3Transcription Factors (Transcription Factor)IBA
01/2018 - 06/2006
3Cetuximab (Erbitux)FDA Link
01/2017 - 01/2016
3Protein Isoforms (Isoforms)IBA
11/2013 - 06/2009
3Platelet-Derived Growth FactorIBA
03/2012 - 09/2007
3Complementary DNA (cDNA)IBA
05/2008 - 09/2004
3beta CateninIBA
05/2008 - 10/2006
3Telomerase (Telomerase Reverse Transcriptase)IBA
09/2006 - 09/2003
2Pioglitazone (Actos)FDA Link
03/2020 - 12/2019
2prolinedithiocarbamate (PDTC)IBA
01/2020 - 02/2013
2TOR Serine-Threonine KinasesIBA
10/2018 - 12/2009
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2017 - 10/2006
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2016 - 09/2011
2Androgen Receptors (Androgen Receptor)IBA
05/2016 - 06/2014
2AndrogensIBA
05/2016 - 06/2014
2PlatinumIBA
01/2016 - 01/2013
2Sirolimus (Rapamycin)FDA Link
01/2016 - 11/2012
2Oncogene Proteins (Oncogene Protein)IBA
08/2015 - 06/2007
2AntigensIBA
02/2015 - 07/2011
2Cell-Free Nucleic AcidsIBA
03/2014 - 09/2006
2IfosfamideFDA LinkGeneric
01/2014 - 12/2011
2AnthracyclinesIBA
12/2013 - 12/2011
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
05/2013 - 03/2012
2Paclitaxel (Taxol)FDA LinkGeneric
01/2013 - 07/2003
2Tumor Biomarkers (Tumor Markers)IBA
04/2012 - 10/2008
2Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
02/2011 - 03/2008
2Beclin-1IBA
10/2010 - 12/2008
2CytokinesIBA
03/2010 - 10/2005
2Fluorouracil (Carac)FDA LinkGeneric
02/2010 - 01/2005
2TensinsIBA
12/2009 - 12/2005
2ErbB Receptors (EGF Receptor)IBA
12/2009 - 07/2005
2CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
06/2009 - 08/2004
2Cyclin D1IBA
10/2008 - 11/2006
2Codon (Codons)IBA
09/2008 - 06/2007

Therapy/Procedure

21Therapeutics
11/2019 - 02/2003
16Drug Therapy (Chemotherapy)
01/2017 - 12/2002
4Radiotherapy
11/2016 - 04/2003